MIND CURIOUS MINDCURE

This episode closes out this season of MIND CURIOUS. Dr. Sherry Walling sits down with co-founder and CEO of Mind Cure Health, Kelsey Ramsden, to chat about the emerging landscape of psychedelic businesses. Kelsey describes her own journey to this market and explores what she's learning as the psychedelic renaissance gains momentum.


Intro (0:00 – 1:42)
Why Psychedelics? (1:43 – 3:54)
The Mental Health Piece (3:55 – 7:35)
The Stigma of Psychedelics (7:36 – 10:31)
A Vulnerable Industry (10:32 – 13:10)
Traditional vs Cutting-Edge (13:11 – 17:18)
Her Inspiration (17:19 – 19:19)
Mountains of Work (19:20 – 20:52)
Meditating on a Rocket (20:53 – 23:43)
End (23:44 – 24:37)

Ketamine is sometimes overlooked in conversations about psychedelics and mental health. Overlooked no more, this conversation with father-son duo Dr. Steven Mandel and Sam Mandel of the Ketamine Clinics of Los Angeles focuses on the many potential uses of ketamine to alleviate mental suffering. We explore why ketamine is potentially underutilized in mental health and examine barriers to access that affect its use.


Intro (0:00 – 1:37)
Their Background (1:38 – 3:45)
The Scope of Their Clinics (3:46 – 5:31)
From Anesthesiology to Ketamine (5:32 – 8:59)
In The Underground (9:00 – 12:32)
Best Practice of Ketamine Treatment (12:33 – 17:03)
How Ketamine is Delivered to the Patient (17:04 – 21:58)
No Talk Therapy (21:59 – 25:23)
Best Practices 2.0 (25:24 – 28:29)
The Role of Dissociation (28:30 – 35:56)
Ketamine’s Usefulness Against Suicidality (35:57 – 41:05)
Final Thoughts (41:06 – 44:18)
End (44:19 – 45:59)

About the guests: https://ketamineclinics.com/about-us/

Full, unedited conversation with Leia Friedman, also known as the Psychedologist. This conversation focuses on the relationship between psychedelics, individual healing, and holistic ecology. Leia shares her own healing journey and how psychedelic work has catalyzed and deepened her relationship with the earth. 

Check out her website: https://thepsychedologist.com/


Intro (0:00 – 1:37) 
Life on a Farm (1:38 – 2:25) 
Settled vs Nomad Life (2:26 – 3:34) 
Lessons from the Land (3:35 – 6:08)
Psychedelics and Her Relationship to the Land (6:09 – 8:37) 
Integrating with Nature (8:38 – 10:52) 
Environmental Justice (10:53 – 14:33) 
Psychedelics’ Role (14:34 – 16:48) 
Balancing Psychedelics with Capitalism (16:49 – 20:51) 
Pros and Cons of Synthesized Ibogaine (20:52 – 26:02) 
Regenerative Solutions (26:03 – 28:45) 
Pleasure as Healing (28:46 – 31:11) 
End (31:12 – 31:57) 

Precision Medicine is a new field that uses data to tailor specific medical interventions to the needs of an individual body. MINDCURE has been pioneering a precision medicine tool, iSTRYM. I asked the experts about how they use large data sets to customize care and what that might mean for the emerging field of psychedelic-supported treatments. Our guests, Dr. John Brownstein and Dr. Ty Tashiro are experts in innovation & big data and mental health-related data science respectively.

Intro (0:00 – 2:24)

First Guest: Dr. John Brownstein (2:25 – 10:30)


What is Precision Medicine?
From Large-Scale to The Individual
Big Brother
Data From Regular Interactions
Data and Psychedelics
From Company to Clinician
The Tools’ Components

Second Guest: Dr. Ty Tashiro (10:31 – 19:12)


ISTRYM’s Technology
Natural Language Processing
Understanding Oneself Better
iSTRYM and Psychedelics (19:13 – 25:27)
Personalized Care
The Mystical Aspect and the Data
The Clinician Experience

End (25:28 – 26:27)

Persistent, recurrent problems with sexual response, desire, orgasm, or pain — that distress you or strain your relationship with your partner — are known medically as sexual dysfunction. The most common sexual dysfunction among women is low sexual desire - a lack of sexual interest and willingness to be sexual. A nationally representative sample of 2207 American households found that the prevalence of low sexual desire ranged from 26.7% among premenopausal women to 52.4% among naturally menopausal women.

MINDCURE is embarking on a clinical trial to test the possibility that MDMA-assisted psychotherapy will effectively treat low desire in women.

Dr. Sherry Walling talks with three experts about the potential that psychedelics may hold for helping to heal desire, including two of MINDCURE's advisors, as well as the company's founder and CEO.

Guests:


Dr. Anita Clayton
Hamilton Morris
Kelsey Ramsden

In this uncut episode, we return to our conversation with Fawad Kalsi to give you his full ibogaine experience, from opioid addiction to hardships to discovering ibogaine, and finally, to recovery.


Intro (0:00 – 1:31)
Intro to Fawad (1:32 – 3:03)
The Start of Fawad’s Addiction (3:04 – 11:20)
Finding Out About Ibogaine (11:21 – 22:42)
Fawad’s Experience with Ibogaine (22:43 – 33:28)
Integrating with Faith (33:29 – 38:10)
His Advice to Others (38:11 – 42:09)
Breaking Religious Stigma (42:10 – 46:23)
Community Pushback (46:24 – 48:03)
End (48:04 – 51:05)